Skip to main content

Meeting Highlights

Meeting Highlights

Lung Cancer, ASCO Highlights

Atezolizumab Extends Disease-Free Survival in PD-L1−Positive Early-Stage NSCLC

Phoebe Starr

Meeting Highlights

Prostate Cancer, ASCO Highlights

¹⁷⁷Lu-PSMA-617 Prolongs Survival in Patients with Metastatic Castration-Resistant Prostate Cancer

Phoebe Starr

Meeting Highlights

ASH Highlights, Leukemia, Novel Pharmaceuticals

Oral Vodobatinib Elicits Durable Responses in Heavily Pretreated Patients with Chronic Myeloid Leukemia

Meeting Highlights

ASH Highlights, Myelofibrosis, Novel Pharmaceuticals

Momelotinib, a Novel JAK Inhibitor, Makes Inroads in Intermediate- or High-Risk Myelofibrosis

Meeting Highlights

ASH Highlights, CAR T-Cell Therapy, Lymphoma

ZUMA-12: Axicabtagene Ciloleucel Shows Substantial Benefit in High-Risk Large B-Cell Lymphoma

Meeting Highlights

ASH Highlights, Clinical Trials, Lymphoma

Step-Up Glofitamab Dosing Induces High Response Rates in Relapsed or Refractory Non-Hodgkin Lymphoma

Meeting Highlights

ASH Highlights, Graft-versus-Host-Disease

Ruxolitinib in Graft-versus-Host Disease: Practice-Changing Results

Meeting Highlights

ASH Highlights, Myelodysplastic Syndromes

Pevonedistat plus Azacitidine Improves Outcomes versus Azacitidine Monotherapy in High-Risk MDS

Meeting Highlights

ASH Highlights

A Phase 2 Study of Isatuximab for Patients with Previously Treated AL Amyloidosis

Meeting Highlights

ASH Highlights

VRD Consolidation Followed by Lenalidomide Maintenance versus Maintenance Alone in Transplant-Eligible Patients with NDMM

1
2
3
4
5
6
7

Page 4 of 17
Results 31 - 40 of 169